In this interview we discuss predictive biomarkers and response to immune checkpoint inhibitors for urothelial tumors, which include tumors of the bladder, ureters, and the renal pelvis.
Padmanee Sharma, MD, PhD
Advertisement
Articles by Padmanee Sharma, MD, PhD
Advertisement
Latest Updated Articles
Predictive Biomarkers and Response to Immunotherapies in Urothelial CancersPublished: January 25th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Anti-TIGIT Combination Therapy Yields Positive Survival in Gastric Cancers
2
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
3
Bridging Radiotherapy Prior to CAR T May Be Safe in R/R Multiple Myeloma
4
Translating CLL Trial Success to Real-World Treatment Application
5
